(Q34098035)
Statements
Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice (English)
U Herz
K Baier
U Neuhaus-Steinmetz
G Dekan
H Renz
C Ebner
R Valenta
1 September 2001